Hepatic Subcapsular Steatosis in a Diabetic CAPD Patient Receiving Subcutaneous Insulin.
- Author:
Seung Yup LEE
1
;
Hyun Kyung KIM
;
Seung Mo KANG
;
Jong Kwan JUNG
;
Eun Ju SONG
;
So Young LEE
Author Information
1. Department of Internal Medicine, Eulji University School of Medicine, Korea. lsymd71@hanmail.net
- Publication Type:Case Report
- Keywords:
Fatty liver;
Peritoneal dialysis;
Diabetes mellitus
- MeSH:
Blood Glucose;
Diabetes Mellitus;
Dialysis;
Fatty Liver;
Female;
Glucose;
Humans;
Injections, Subcutaneous;
Insulin;
Liver;
Middle Aged;
Peritoneal Dialysis;
Peritoneal Dialysis, Continuous Ambulatory
- From:Korean Journal of Nephrology
2011;30(5):557-560
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hepatic subcapsular steatosis is a rare and unique form of fatty change in the liver. It is a specific finding in diabetic patients receiving continuous ambulatory peritoneal dialysis (CAPD) and intraperitoneal insulin treatment. Intraperitoneal administration of insulin and high glucose cause a unique pattern of fatty infiltration in the subcapsular location of the liver. We report a case of hepatic subcapsular steatosis in a diabetic CAPD patient who has not received intraperitoneal insulin. A 63-year-old diabetic woman on CAPD presented with uncontrolled blood glucose. The patient received a total amount of 44 units of NPH via subcutaneous injection. Her initial blood chemistry showed mildly increased serum lipid profiles. Abdominal CT scan images and MRI revealed characteristic findings consistent with hepatic subcapsular steatosis. We report a case of hepatic subcapsular steatosis in a diabetic patient not taking intraperitoneal insulin who recovered through strict blood sugar control without changing dialysis modality.
